Concepedia

Publication | Open Access

Analysis of Dermatologic Events in Vemurafenib-Treated Patients With Melanoma

DOIFull Paper Access

213

Citations

25

References

2013

Year

Mario E. Lacouture, Madeleine Duvic, Axel Hauschild, Víctor G. Prieto, Caroline Robert, Dirk Schadendorf, Caroline C. Kim, Christopher McCormack, Patricia L. Myskowski, Olivia Spleiss,
The Oncologist

Abstract

Dermatologic AEs associated with vemurafenib treatment in patients with melanoma were generally manageable with supportive care measures. Dose interruptions and/or reductions were required in <10% of patients.

References

YearCitations

Page 1